Definition:
The market Other Pharmaceuticals covers revenues for areas that are not specifically mentioned in the other markets, such as psychotropic or gastroenterology drugs and less expensive but widely used drugs, such as cold and cough remedies or analgesics.
Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Jun 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Other Pharmaceuticals market in Estonia has been experiencing notable growth in recent years.
Customer preferences: Estonian consumers have been showing an increasing demand for Other Pharmaceuticals, which includes over-the-counter medications, vitamins, and supplements. This can be attributed to a growing focus on personal health and wellness, as well as a desire for self-care and prevention of illnesses.
Trends in the market: One trend that has been observed in the Other Pharmaceuticals market in Estonia is the rise of e-commerce. More and more consumers are turning to online channels to purchase their medications and supplements, which has led to increased competition among retailers. Additionally, there has been a shift towards natural and organic products, with many consumers seeking out supplements and vitamins made from natural ingredients.
Local special circumstances: Estonia has a relatively small population, which has led to a limited number of domestic manufacturers in the Other Pharmaceuticals market. This has resulted in a reliance on imports from other countries, particularly neighboring Finland and Sweden. However, the Estonian government has been taking steps to support the growth of domestic manufacturers, which could lead to increased competition and innovation in the market.
Underlying macroeconomic factors: Estonia has a strong and stable economy, which has contributed to the growth of the Other Pharmaceuticals market. Additionally, the country has a well-developed healthcare system, which has led to increased access to healthcare services and medications. However, the aging population in Estonia could present a challenge to the market in the future, as older individuals tend to require more medications and supplements.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Sep 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights